Shreya Chakraborty

Shreya Chakraborty is a Ph.D. candidate at the Indian Institute of Science Bengaluru. Her doctoral thesis focuses on understanding genetic architecture of manifestations of neurodegenerative diseases, with a specific focus on human cognition, considering age-associated metabolic risks. She has publications in peer-reviewed international journals with high reach and has presented papers at national and international conferences. She is a recipient of the Prime Minister Research Fellowship from the Government of India, which funds her research at IISc Bangalore.

Shreya holds a bachelor’s and a master’s degree in statistics from St. Xavier’s College, Kolkata and the University of Calcutta. She received the South-East Asia Subsistence fellowship for securing the highest marks at the undergraduate level in her university. Before starting her doctoral studies, she worked as an analyst at Marketing Management Analytics, Ipsos Research Pvt. Ltd.

As a Fulbright-Nehru Doctoral Research fellow, Shreya is focusing on building statistical models that enhance the translation of genetic risk prediction (polygenic risk portability) of cognitive decline across diverse contexts, taking underlying genomic architecture and interactions into account. Since polygenic risk score prediction has direct clinical utility, drawing context-specific predictions, would form a knowledge base for specific target genetic regions for accelerated cognitive decline during aging. Apart from research, she takes a great interest in participating and organizing cultural events, especially when they involve music. Shreya loves spending time with her friends and family, and also enjoys travelling and meeting people from various cultures.

Ajay Gogia

Dr Ajay Gogia is an Additional Professor in the Department of Medical Oncology at All India Institute of Medical Sciences. He received his M.B.B.S, M.D. (Internal Medicine) degree from Banaras Hindu University, D.M. (Medical Oncology) from AIIMS, New Delhi.

He has over 17 years of working and teaching experience in Medical Oncology and specializes in Breast Cancer and Non-Hodgkin’s Lymphoma. His research is well published with more than 400 peer-reviewed articles in National and International oncology journals He has received the Dronacharya Award for his excellence from the Health Minister of India.

Dr. Ajay Gogia’s Fulbright-Nehru project aims to understand the molecular pathogenesis of triple-negative breast cancer (TNBC) and see the impact of Carboplatin and /or PARP inhibitor with standard dose-dense neoadjuvant chemotherapy on BRCA-associated triple-negative breast cancer. The precise stratification of TNBC is crucial for the development of potent standardized and targeted therapies, as it has a very poor prognosis. BRCA mutational status is the only clinically validated biomarker for personalized therapy in TNBC.